Financhill
Back

Sarepta Therapeutics Vs. Pfizer Industry Stock Comparison

Sell
38

SRPT
Sarepta Therapeutics

Last Price:
124.63
Seasonality Move:
1.34%
Sell
32

PFE
Pfizer

Last Price:
29.26
Seasonality Move:
5.17%
Sell
38
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.65. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Pfizer (PFE) is a Sell

Is Pfizer a Buy, Sell or Hold?

  • The current Pfizer [PFE] share price is $29.27. The Score for PFE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PFE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PFE Stock Price Chart

What is Pfizer's stock price today?

  • The Pfizer share price today is $29.27
    The current trend is moderately bullish and PFE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.68 Sell
Relative Strength Index (14 RSI): 30.09 Sell
Chaikin Money Flow: 598042 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.39 - 139.55) Sell
Bollinger Bands (100): (124.32 - 147.66) Sell

PFE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 53.36 Buy
Chaikin Money Flow: 13694705 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.48 - 29.22) Buy
Bollinger Bands (100): (27.46 - 29.66) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.83 Sell
20-day SMA: 134.77 Sell
50-day SMA: 140.11 Sell
200-day SMA: 125.53 Sell
8-day EMA: 128.61 Sell
20-day EMA: 132.8 Sell
50-day EMA: 136.16 Sell
200-day EMA: 128.98 Sell

PFE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.09 Buy
20-day SMA: 28.9 Buy
50-day SMA: 29.19 Buy
200-day SMA: 28.13 Buy
8-day EMA: 29.18 Buy
20-day EMA: 29.05 Buy
50-day EMA: 28.95 Buy
200-day EMA: 29.48 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Pfizer Earnings Growth & PFE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.93 per share, an increase next quarter of $0.06 per share, an increase this year of $1.11 per share, and an increase next year of $0.22 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pfizer Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):